Genus (GNS) Stock Rating Reaffirmed by Peel Hunt
GNS has been the topic of several other reports. HSBC restated a buy rating and issued a GBX 2,700 ($35.28) price objective (up from GBX 2,650 ($34.63)) on shares of Genus in a research report on Monday, March 11th. Liberum Capital upgraded shares of Genus to a buy rating and upped their price objective for the stock from GBX 2,400 ($31.36) to GBX 2,500 ($32.67) in a research report on Tuesday, March 5th. Finally, Kepler Capital Markets upgraded shares of Genus to a buy rating and upped their price objective for the stock from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a research report on Thursday, December 6th.
GNS stock opened at GBX 2,194 ($28.67) on Monday. The company has a current ratio of 2.08, a quick ratio of 1.32 and a debt-to-equity ratio of 22.58. The company has a market capitalization of $1.41 billion and a P/E ratio of -203.15. Genus has a 1-year low of GBX 2,090 ($27.31) and a 1-year high of GBX 2,998 ($39.17).
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Story: Stochastic Momentum Index (SMI)
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.